These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5764800)

  • 21. [Conservative treatment of arterial occlusions].
    Frisch P
    Med Klin; 1969 Feb; 64(8):323-6. PubMed ID: 5783018
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood supply measurement of the extremities, estimation of microcirculation and heart circulation screening with an occluded vein plethysmographic method. III. Instructions for occluded vein plethysmography investigations].
    Hackel F
    Z Arztl Fortbild (Jena); 1975 Oct; 69(19):1033-5. PubMed ID: 1210396
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences with Lamuran in chronic arterious circulatory disorders and in a case of femoral embolism].
    Siebert U
    Z Allgemeinmed; 1972 Mar; 48(9):442-4. PubMed ID: 5034162
    [No Abstract]   [Full Text] [Related]  

  • 24. [Report on the treatment of ocular blood circulation disorders with raubasin].
    Genée E
    Med Welt; 1968 Aug; 33():1773-81. PubMed ID: 5712285
    [No Abstract]   [Full Text] [Related]  

  • 25. [Physical therapy in peripheral arterial circulatory disorders: influence of partial baths with roast chestnut extract addition (Hoevenol) on the leg blood circulation and on kidney hemodynamics].
    Hackel F
    Arch Phys Ther (Leipz); 1970; 22(6):339-46. PubMed ID: 5531612
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methods for peripheral arterial flow measurement].
    Somer T
    Duodecim; 1972; 88(6):471-80. PubMed ID: 4552222
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medicinal prevention and therapy of arterial occlusive diseases of the extremities].
    Hild R
    Dtsch Med J; 1967 May; 18(10):306-12. PubMed ID: 5612094
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined use of alpha-methyldopa, Rauwolfia alkaloids and thiabutazide in the treatment of arterial hypertension].
    Leonhard H
    Med Welt; 1965 Aug; 35():1979-84. PubMed ID: 5843994
    [No Abstract]   [Full Text] [Related]  

  • 29. [On prolonged treatment of phlebopathic patients with a combination of vasoactive and vasoprotective drugs. Rheographic study].
    Rizzi B; Giacomini F; Terni E; Zullini ML
    Minerva Cardioangiol; 1971 Feb; 19(2):73-85. PubMed ID: 5572860
    [No Abstract]   [Full Text] [Related]  

  • 30. [On prolonged hemokinetic therapy of occlusive arterial diseases].
    Alegría A
    Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Induced blood circulation and diuresis as intensive treatment in acute poisoning].
    Bachmann K; Demling L
    Verh Dtsch Ges Inn Med; 1968; 74():876-9. PubMed ID: 5714439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reaction of the blood circulation in the extremities with intravenous Raubasin infusions].
    Schütz RM; Kramer H
    Med Welt; 1971 Apr; 14():554-9. PubMed ID: 5551941
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the electrolytic picture and in the glucidic metabolism in the course of treatment with an hypotensive combination of hypertensive patients with peripheral arteriopathies].
    Costantini S; Tardito E; Boeri S
    Minerva Cardioangiol; 1969 Nov; 17(11):948-60. PubMed ID: 5404823
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of arterial, peripheral and cerebral circulatory disorders. Clinical results using intravenous infusions of complamine].
    Kunert W; Lietz W
    Fortschr Med; 1972 Dec; 90(35):1315-7. PubMed ID: 4658025
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of essential arterial hypertension by the methyclothiazide-deserpidine].
    de Faria CV
    Rev Bras Med; 1967 May; 24(5):331-3. PubMed ID: 5603874
    [No Abstract]   [Full Text] [Related]  

  • 36. [Level and dynamics of blood pressure at various vascular zones in patients with hypertension].
    Geller LI; Mashchenko RG; Lukashevich OP; Petrenko VF
    Klin Med (Mosk); 1969 Jul; 47(7):118-22. PubMed ID: 5385075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antiarrhythmic drugs and ajmaline (contribution to the clinical use of ajmaline in therapy of cardiac arhythmias)].
    Artese D
    Riforma Med; 1965 Oct; 79(44):1216-22. PubMed ID: 5857477
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the vectorcardiogram under the influence of treatment with rauwolfia preparations].
    Trebler LIa
    Ter Arkh; 1967 Jul; 39(7):70-4. PubMed ID: 5610934
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term treatment of hypertension with a preparation combining rauwolfia and bendroflumethiazide.
    Hutchison JC
    Med Times; 1967 Aug; 95(8):860-8. PubMed ID: 6046238
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ajmaline, an alkaloid of Rauwolfia serpentina, in the treatment of cardiac arrhythmias].
    Bazika V
    Vnitr Lek; 1969 Jul; 15(7):662-70. PubMed ID: 5805145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.